focus -WSS

focus

author：explore 2025-09-30 00:02:54 - browse：8

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Fetal cell organoids grown from amniotic fluid, study finds

WSS

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Ozempic has benefits for kidney disease as well as diabetes

Why Talkspace is targeting Medicare, a tricky market

In key trial, Verve's treatment lowers cholesterol levels in patients

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Why Talkspace is targeting Medicare, a tricky market

focus

focus

hotspot

At least 13 dead in Texas as scorching temps continue

A new approach to psychiatric drug development

In Memoriam: Notable people who died in 2023

Morphosys mixed study results for blood cancer drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

A new approach to psychiatric drug development

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NYU radiologists take on the challenge of expensive MRI machines

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Lack of health data on LGBTQ+ people has serious consequences

entertainment

World's first CRISPR

World's first CRISPR

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Ozempic has benefits for kidney disease as well as diabetes

Morphosys mixed study results for blood cancer drug

$1 billion proposal to grow Boston, Massachusetts biotech

knowledge

hotspot

hotspot

hotspot